Transcriptional regulation in prostate cancer

DP Labbé, M Brown - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Prostate cancer development involves corruption of the normal prostate transcriptional
network, following deregulated expression or mutation of key transcription factors. Here, we …

Integrative detection and analysis of structural variation in cancer genomes

JR Dixon, J Xu, V Dileep, Y Zhan, F Song, VT Le… - Nature …, 2018 - nature.com
Structural variants (SVs) can contribute to oncogenesis through a variety of mechanisms.
Despite their importance, the identification of SVs in cancer genomes remains challenging …

Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer

N Manzar, P Ganguly, UK Khan, B Ateeq - Seminars in Cancer Biology, 2023 - Elsevier
Transcription factors (TFs) represent the most commonly deregulated DNA-binding class of
proteins associated with multiple human cancers. They can act as transcriptional activators …

A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis

H Zou, B Poore, EE Brown, J Qian, B Xie… - Nature cell …, 2023 - nature.com
How abnormal neurodevelopment relates to the tumour aggressiveness of medulloblastoma
(MB), the most common type of embryonal tumour, remains elusive. Here we uncover a …

Differential impact of RB status on E2F1 reprogramming in human cancer

C McNair, K Xu, AC Mandigo, M Benelli… - The Journal of …, 2018 - Am Soc Clin Investig
The tumor suppressor protein retinoblastoma (RB) is mechanistically linked to suppression
of transcription factor E2F1-mediated cell cycle regulation. For multiple tumor types, loss of …

DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2

R Kaarijärvi, H Kaljunen, L Nappi, L Fazli… - Communications …, 2024 - nature.com
Abstract Treatment-induced neuroendocrine prostate cancer (t-NEPC) is a lethal subtype of
castration-resistant prostate cancer resistant to androgen receptor (AR) inhibitors. Our study …

[HTML][HTML] Transcriptional landscape of human cancers

M Li, Q Sun, X Wang - Oncotarget, 2017 - ncbi.nlm.nih.gov
The homogeneity and heterogeneity in somatic mutations, copy number alterations and
methylation across different cancer types have been extensively explored. However, the …

The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility?

JN Chun, M Cho, S Park, I So, JH Jeon - Biochimica et Biophysica Acta …, 2020 - Elsevier
The transcription factor E2F1 plays a crucial role in mediating multiple cancer hallmark
capabilities that regulate cell cycle, survival, apoptosis, metabolism, and metastasis …

Epigenetic regulation in prostate cancer progression

K Ruggero, S Farran-Matas, A Martinez-Tebar… - Current molecular …, 2018 - Springer
Abstract Purpose of Review An important number of newly identified molecular alterations in
prostate cancer affect gene encoding master regulators of chromatin biology epigenetic …

NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1

Z Jing, Q Liu, W Xie, Y Wei, J Liu, Y Zhang, W Zuo… - Cellular signalling, 2022 - Elsevier
NCAPD3 is one of the non-SMC regulatory subunits of Condensin II, which is mainly
responsible for the condensation and segregation of chromosomes during mitosis. However …